OssDsign Gains 510(k) for Indication in Interbody Cages

OssDsign's nanosynthetic bone graft OssDsign Catalyst received FDA 510(k) clearance for use in interbody cages in spinal surgery, allowing surgeons to use OssDsign Catalyst on-label in any interbody cage cleared for use with synthetic bone grafts. OssDsign Catalyst is reported to be the first synthetic bone graft to be cleared to market for...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us